Cargando…

Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus

BACKGROUND: New guidelines for the treatment of human immunodeficiency virus (HIV) suggest that morbidity and mortality could be reduced if antiretroviral therapy (ART) was initiated immediately after diagnosis, regardless of CD4 cell count. OBJECTIVE: To assess real-world time to ART initiation and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benson, Carmela, Emond, Bruno, Romdhani, Hela, Lefebvre, Patrick, Côté-Sergent, Aurélie, Shohoudi, Azadeh, Tandon, Neeta, Chow, Wing, Dunn, Keith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391060/ https://www.ncbi.nlm.nih.gov/pubmed/31747357 http://dx.doi.org/10.18553/jmcp.2019.19174

Ejemplares similares

Rapid Initiation of Antiretroviral Therapy Following Diagnosis of Human Immunodeficiency Virus Among Patients with Commercial Insurance Coverage
por: Benson, Carmela, et al.
Publicado: (2020)

Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV
por: Dunn, Keith, et al.
Publicado: (2018)

Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate
por: Emond, Bruno, et al.
Publicado: (2018)

Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate
por: Patel, Charmi, et al.
Publicado: (2019)

Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study
por: Emond, Bruno, et al.
Publicado: (2021)

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
por: Pilon, Dominic, et al.
Publicado: (2017)

Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics
por: Pilon, Dominic, et al.
Publicado: (2021)

Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide
por: Chow, Wing, et al.
Publicado: (2020)

Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or Chemoimmunotherapy
por: Emond, Bruno, et al.
Publicado: (2019)

Health Care of Vulnerable Populations Covered by Medicare and Medicaid
por: Hirsch, Marilyn B.
Publicado: (1994)

Distance traveled for Medicaid-covered abortion care in California
por: Johns, Nicole E., et al.
Publicado: (2017)

Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics
por: Lafeuille, Marie-Hélène, et al.
Publicado: (2018)

A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia
por: Lin, Dee, et al.
Publicado: (2023)

Economic consequences for Medicaid of human immunodeficiency virus infection
por: Baily, Mary Ann, et al.
Publicado: (1990)

New Jersey's Medicaid waiver for acquired immunodeficiency syndrome
por: Merzel, Cheryl, et al.
Publicado: (1992)

Association of Medicaid expansion with dental emergency department visits overall and by states’ Medicaid dental benefits provision
por: Giannouchos, Theodoros V., et al.
Publicado: (2023)

Community Health Centers Maintained Initial Increases in Medicaid Covered Adult Patients at 5-Years Post-Medicaid-Expansion
por: Goldstein, Evan V.
Publicado: (2021)

Correction: Association of Medicaid expansion with dental emergency department visits overall and by states’ Medicaid dental benefits provision
por: Giannouchos, Theodoros V., et al.
Publicado: (2023)

Longitudinal patterns of California Medicaid recipients with acquired immunodeficiency syndrome
por: Andrews, Roxanne, et al.
Publicado: (1991)

Acquired immunodeficiency syndrome in California's Medicaid program, 1981-84
por: Andrews, Roxanne M., et al.
Publicado: (1988)

Medicaid Eligibility and Time to Re-incarceration Among Previously Incarcerated Subjects With Schizophrenia
por: Kozma, Chris, et al.
Publicado: (2016)

Estimating the proportion of Medicaid-eligible pregnant women in Louisiana who do not get abortions when Medicaid does not cover abortion
por: Roberts, Sarah C. M., et al.
Publicado: (2019)

Covering Uninsured Adults Through Medicaid: Lessons from the Oregon Health Plan
por: Haber, Susan G., et al.
Publicado: (2000)

Twenty years of Medicare and Medicaid: Covered populations, use of benefits, and program expenditures
por: Gornick, Marian, et al.
Publicado: (1985)

Medicaid home and community-based waivers for acquired immunodeficiency syndrome patients
por: Lindsey, Phoebe A., et al.
Publicado: (1990)

1849. Impact of Medicaid Expansion on Human Immunodeficiency Virus Outcomes in Nebraska
por: McCluskey, James M, et al.
Publicado: (2023)

Demographic risk factors associated with elevated lead levels in Texas children covered by Medicaid.
por: Kurtin, D, et al.
Publicado: (1997)

Prospective Service Use and Health Care Costs of Medicaid Beneficiaries with Treatment-Resistant Depression
por: Olfson, Mark, et al.
Publicado: (2018)

Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia
por: Pilon, Dominic, et al.
Publicado: (2017)

Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates
por: Le Grand, Roger, et al.
Publicado: (2016)

Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia
por: Basu, Anirban, et al.
Publicado: (2018)

Determinants of antepartum human immunodeficiency virus testing in a non-Medicaid obstetric population.
por: Cardonick, E, et al.
Publicado: (1998)

Utilization and spending trends for antiretroviral medications in the U.S. Medicaid program from 1991 to 2005
por: Jing, Yonghua, et al.
Publicado: (2007)

Predictors of chronic opioid therapy in Medicaid beneficiaries with HIV who initiated antiretroviral therapy
por: Oh, GYeon, et al.
Publicado: (2021)

Introducing ground cover management in pesticide emission modeling
por: Gentil‐Sergent, Céline, et al.
Publicado: (2021)

‘Covering the tail’ after stopping efavirenz-based antiretroviral therapy
por: Maartens, Gary
Publicado: (2020)

Expenditures for ambulatory episodes of care: The Michigan Medicaid experience
por: McDevitt, Roland D., et al.
Publicado: (1989)

Medicaid Becomes the First Third-Party Payer to Cover Passive Remote Monitoring for Home Care: Policy Analysis
por: Berridge, Clara
Publicado: (2018)

Does Medicaid cover artificial urinary sphincter and male urethral sling surgery?—a state-by-state analysis
por: Soltanzadeh Zarandi, Sina, et al.
Publicado: (2023)

Trends and Predictors of Glycemic Control Among Adults With Type 2 Diabetes Covered by Alabama Medicaid, 2011–2019
por: Presley, Caroline A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6tg2se8g0m86a38qd11agpddu1